Ameritas Investment Partners’s Zymeworks ZYME Stock Holding History

Ameritas Investment Partners’s Portfolio ZYME Stock Details ZYME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$109K	Hold	4,164	–	–	﹤0.01%	1780
2026 Q1	$104K	Hold	4,164	–	–	﹤0.01%	1674
2025 Q4	$110K	Hold	4,164	–	–	﹤0.01%	1640
2025 Q3	$71.1K	Sell	4,164 -1,452	-26%	-$20.8K	﹤0.01%	1901
2025 Q2	$70.5K	Hold	5,616	–	–	﹤0.01%	1969
2025 Q1	$66.9K	Hold	5,616	–	–	﹤0.01%	1943
2024 Q4	$82.2K	Hold	5,616	–	–	﹤0.01%	1897
2024 Q3	$70.5K	Hold	5,616	–	–	﹤0.01%	1993
2024 Q2	$47.8K	Hold	5,616	–	–	﹤0.01%	2160
2024 Q1	$59.1K	Hold	5,616	–	–	﹤0.01%	2051
2023 Q4	$58.4K	Buy	5,616 +1,208	+27%	+$9.63K	﹤0.01%	2077
2023 Q3	$27.9K	Hold	4,408	–	–	﹤0.01%	2387
2023 Q2	$38.1K	Buy	+4,408	New	+$39.5K	﹤0.01%	2207

Other funds holding ZYME

EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

Ameritas Investment Partners's ZYME Position: Q2 2026 in Review

Ameritas Investment Partners held its Zymeworks (ZYME) position steady in Q2 2026 at 4,164 shares worth $109K. The position accounts for ﹤0.01% of the portfolio, ranked #1780.

Ameritas Investment Partners first reported a position in ZYME in Q2 2023 and has held it in 13 quarters since. The position peaked at $110K in Q4 2025. 202 funds tracked by Wall St. Rank hold ZYME as of Q2 2026.

Ameritas Investment Partners held 4,164 shares of Zymeworks worth $109K as of Q2 2026.
Ameritas Investment Partners left its Zymeworks share count unchanged in Q2 2026.
Zymeworks made up ﹤0.01% of Ameritas Investment Partners's portfolio in Q2 2026, its #1780 holding.
Ameritas Investment Partners first reported a position in Zymeworks in Q2 2023 and has held it in 13 quarters since.
Ameritas Investment Partners's Zymeworks position peaked at $110K in Q4 2025.
202 funds tracked by Wall St. Rank held Zymeworks as of Q2 2026.

Based on Ameritas Investment Partners's 13F filing for Q2 2026, filed 13 Aug 2026.